Data as of Jul 25, 2026 · Based on 2,718,867 AI responses across 9,511 prompts · See how Parse measures this
Invest Michiganinvestmichigan.org · Low evidenceGenomenon is an AI-driven genomics company that curates and structures patient-level evidence from the scientific literature into a clean, clinically relevant dataset. Its Genomenon Genomic Graph (G3) knowledgebase aggregations include genes, variants (including copy number and structural variants), disease-gene relationships, drugs, phenotypes, and patient demographics from the indexed literature to power AI-driven models for diagnostics and drug development. The company markets a literature-derived Real-World Evidence (RWE) platform that complements EHR and claims data to guide indication strategy, patient cohort discovery, regulatory submissions, and expansion of targeted therapies, with 75+ RWE programs delivered for 25 pharma partners.
Parse Score